INTRODUCTION
============

Mitochondria play a crucial role in the production of cellular energy. Under aerobic conditions, the mitochondrial respiratory chain uses electrons derived from catabolic reactions to establish a proton gradient across the inner mitochondrial membrane. This proton gradient drives the F~1~F~o~ATPase to generate ATP from ADP and P~i~. The F~1~F~o~ATPase is a multisubunit enzyme ([@B11]; [@B7]) consisting of the membrane-spanning domain F~o~, responsible for H^+^ translocation, and the F~1~ domain, which contains the catalytic sites for ATP synthesis ([@B7]; [@B21]; [@B63]). Whereas the enzymatic function of the F~1~F~o~ATPase has been extensively analyzed, recent analyses have attributed a second function to it. Besides its role in energy metabolism, the F~1~F~o~ATPase was also shown to play an important role for the morphology and organization of the inner mitochondrial membrane ([@B26]; [@B47]; [@B23]; [@B61]; [@B64]; [@B15]). The inner membrane of mitochondria forms cristae, which fold inwards toward the mitochondria lumen, and the inner boundary membrane, which aligns with the outer membrane to form the typical double-membrane layered structure of mitochondria. The short tubular connection between the inner boundary and the cristae membrane is termed the cristae junction. The oligomerization of the F~1~F~o~ATPase is believed to be critical for cristae tip formation by promoting positive curvature of the inner membrane.

The F~1~F~o~ATPase exists primarily as a monomeric or homodimeric form ([@B2]; [@B40]; [@B70]). Moreover, higher oligomeric states of the F~1~F~o~ATPase homodimers were found in various organisms ([@B20]; [@B34]; [@B61]; [@B15]). The F~1~F~o~ATPase homodimers form ribbons in the cristae membrane, which influence the physical properties of the lipid bilayer ([@B59]; [@B48]; [@B14]).

In *Saccharomyces cerevisiae*, various proteins have been identified to act as dimerization factors for the F~1~F~o~ATPase. The ATPase subunits g (Atp20), e (Atp21), k (Atp19), and i (Atp18) associate to the F~o~ portion of the monomers to mediate formation or stabilization of the dimeric form ([@B2]; [@B46]; [@B58]; [@B67]). However, Atp20, Atp21, Atp19, and Atp18 are not essential for ATPase activity ([@B1], [@B2], [@B3]; [@B62]; [@B48]). Atp18, Atp20, and Atp21 are of low molecular weight (around 12 kDa) and contain predicted membrane-spanning regions ([@B1], [@B2]; [@B58]; [@B46]; [@B68], [@B67]). Furthermore, subunits Atp20 and Atp21 contain a characteristic GxxxG motif in their transmembrane domain. Glycine-rich motives are believed to be important for helix--helix packing in the lipid bilayer ([@B52]). In the case of Atp20 and Atp21, these motifs are considered to be critical to stabilize the interaction between F~1~F~o~ATPase monomers ([@B4]; [@B9]; [@B53]).

The higher oligomeric states of the F~1~F~o~ATPase are involved in maintaining mitochondrial ultrastructure by promoting membrane curvature and tubular cristae membrane formation ([@B26]; [@B47]; [@B23]; [@B64]). Thus the absence of dimerization factors Atp20 and Atp21 leads to altered mitochondrial morphology called "onion-like structures" ([@B47]; [@B5]), referring to a layered arrangement of the inner membrane. Moreover, Atp20 has been shown to undergo posttranslational modification. Reversible phosphorylation of Atp20 switches its function, reflecting that the dimerization process is regulated in vivo ([@B49]).

Proper ultrastructure of the mitochondrial inner membrane is dependent on an antagonism between Atp20/Atp21 and Fcj1 (formation of cristae junction 1). Fcj1 was suggested to affect mitochondrial cristae by destabilizing F~1~F~o~ATPase oligomers ([@B48]; [@B64]). Hence absence of Fcj1 increases the amount of F~1~F~o~ATPase synthase oligomers and thus favors cristae tip over cristae junction formation ([@B48]). This process appears to be conserved in mammals. Mitofilin, the mammalian homologue of Fcj1, and inner membrane proteins such as Opa1, MICS1, and CHCHD3 and F~1~F~o~ATPase dimerization affect cristae and mitochondrial morphology through cristae junction formation and opening ([@B44]; [@B31]; [@B22]; [@B43]; [@B39]; [@B13]; [@B15]). Hence knockdown of Mitofilin leads to altered cristae morphology, exemplified by an overall change in mitochondrial inner membrane organization, decrease in cristae junctions, and formation of tubular cristae ([@B31]; [@B39]). Moreover, mitofilin has been found to associate with outer membrane protein complexes, thereby aiding attachment of cristae junctions to the outer membrane ([@B42]; [@B31]; [@B73]).

Whereas dimerization and formation of higher oligomers of the F~1~F~o~ATPase is well studied in yeast, insight is lacking on this process in higher eukaryotes. To identify novel F~1~F~o~ATPase synthase oligomerization factors in human cells, we performed an in silico analysis and identified a conserved uncharacterized mitochondrial protein that we termed MINOS1. Detailed analyses revealed that human MINOS1 and its yeast orthologue Mio10 did not associate with the F~1~F~o~ATPase. However, we show that MINOS1/Mio10 plays a central role in the maintenance of mitochondrial morphology as part of the mitofilin/Fcj1 complex.

RESULTS
=======

Identification of MINOS1/Mio10
------------------------------

Assembly of the F~1~F~o~ATPase into dimers and higher oligomers is critical for mitochondrial cristae formation in yeast mitochondria ([@B8]; [@B5]; [@B17]; [@B59]; [@B48]). The small membrane proteins Atp20 (subunit g) and Atp21 (subunit e; Tim11) are important for dimerization of the F~1~F~o~ATPase and are characterized by the presence of a glycine-rich region. To identify potential novel oligomerization factors for the F~1~F~o~ATPase in yeast and human we performed an in silico analysis for proteins with a molecular weight \<12 kDa that had been localized to mitochondria in large-scale analyses ([@B56]; [@B50]). This analysis revealed Atp20 and Atp21, as well as 17 uncharacterized proteins (Supplemental Figure S1A). Only two of the uncharacterized membrane proteins contained a glycine-rich segment and displayed significant sequence similarity to a human protein (Supplemental Figure S1B). Here we analyzed YCL057C-A (Mio10, Mos1, Mcs10), which displayed similarity with human C1orf151 ([Figure 1A](#F1){ref-type="fig"}). We later refer to these proteins as Mio10 (yeast) and MINOS1 (human). Mio10 and MINOS1 are highly conserved among a large number of eukaryotes (Supplemental Figure S2).

![MINOS1 and Mio10 are conserved mitochondrial inner membrane proteins. (A) Alignment of Mio10 homologues (ClustalW 2.0.11). Black boxes indicate identical residues in at least four species; gray boxes indicate similar amino acids ([@B19]). *Sc*, *S. cerevisiae*; *Ag*, *Ashbya gossypii*; *Nc*, *Neurospora crassa*; *Mm*, *Mus musculus; Hs*, *Homo sapiens.* (B) Organization of *S. cerevisiae* Mio10. Black boxes, predicted transmembrane domains (TMs). (C) Subcellular localization of MINOS1 and cyclophilin D in Vero cells by immunofluorescence. Bars, 10 μm. (D) Western blot analyses of the submitochondrial localization and (E) membrane association of MINOS1 as described in *Materials and Methods*. (F) Analyses of the submitochondrial localization and (G) membrane association of Mio10 by Western blotting. T indicates the total; S and P indicate the supernatant and pellet after ultracentrifugation. TX-100, Triton X-100; PK, proteinase K.](247fig1){#F1}

Primary sequence analyses revealed that Mio10 and MINOS1 contain two predictable transmembrane segments separated by a short stretch of charged residues but lack an appreciable N-terminal presequence ([Figure 1B](#F1){ref-type="fig"}). We therefore assessed whether MINOS1 was a mitochondrial protein by immunofluorescence microscopy. These analyses revealed a primarily mitochondrial localization pattern of MINOS1 in Vero cells that could be superimposed on the distribution of the mitochondrial marker cyclophilin D ([Figure 1C](#F1){ref-type="fig"}). To address the submitochondrial localization of MINOS1, we performed biochemical fractionation analyses in HEK293T cells. MINOS1 was detected in purified human mitochondria by Western blotting ([Figure 1D](#F1){ref-type="fig"}, lane 1, and Supplemental Figure S3A) and displayed resistance to protease treatment in mitochondria, whereas the outer membrane protein TOM70 was sensitive to the protease. However, MINOS1 became accessible to the protease when the outer membrane was disrupted by osmotic swelling (mitoplasts; [Figure 1D](#F1){ref-type="fig"}). Thus MINOS1 behaved in similar way to the inner membrane protein TIM23, indicating that the protein was exposed to the intermembrane space (IMS). Because MINOS1 was predicted to be a membrane protein, we addressed its membrane association by alkaline extraction. As expected, MINOS1 was resistant to alkaline extraction, whereas peripheral membrane proteins such as TACO1 were efficiently released into the supernatant at high pH ([Figure 1E](#F1){ref-type="fig"}). Thus we concluded that MINOS1 was an integral membrane protein of the inner membrane in human mitochondria.

For comparison, we addressed the localization of Mio10 in yeast by protease protection analyses of isolated mitochondria ([Figure 1F](#F1){ref-type="fig"} and Supplemental Figure S3B). Similar to MINOS1, Mio10 remained protected against proteolysis in mitochondria but became accessible to the treatment in mitoplasts ([Figure 1F](#F1){ref-type="fig"}). Because the antibody against Mio10 was directed against a C-terminal peptide, we concluded that the C-terminus was exposed to the intermembrane space. Moreover, similar to the human protein, Mio10 displayed resistance to alkaline extraction, indicating that it was an integral inner membrane protein. We concluded that MINOS1 and Mio10 are integral inner membrane proteins with their C-termini exposed to the IMS. Based on the prediction of two transmembrane-spanning regions, we suggest that they display a topology in which both termini localize to the intermembrane space.

MINOS1 is not stably associated with the F~1~F~o~ATPase
-------------------------------------------------------

We tested whether MINOS1 was associated with the F~1~F~o~ATPase in the inner mitochondrial membrane. After solubilization of human mitochondria from HEK293T cells in digitonin-containing buffer, which maintains the protein complexes in their oligomeric state ([@B54]; [@B40]), we performed immunoprecipitation analyses with anti-F~1~F~o~ATPase and anti--cytochrome *c* oxidase antiserum as a control. Both immunoprecipitations efficiently isolated the corresponding complexes, as indicated by the presence of COX1 and COX6A1 in the anti--cytochrome *c* oxidase and F1β in the anti-F~1~F~o~ATPase precipitate. However, MINOS1 was not recovered in the immunoprecipitates ([Figure 2A](#F2){ref-type="fig"}). Similarly, we tested whether Mio10 was associated with the F~1~F~o~ATPase in yeast, using a ZZ tag on the Atp20 protein. Despite an efficient immunoprecipitation of the complex from digitonin-solubilized mitochondria (indicated by the presence of Atp5 in the eluate), we did not detect significant amounts of Mio10 in the precipitate ([Figure 2B](#F2){ref-type="fig"}). Thus we concluded that MINOS1/Mio10 are not stably associated with the F~1~F~o~ATPase in human or yeast mitochondria.

![MINOS1 and Mio10 are not associated with the F~1~F~0~ATPase. (A) Coimmunoprecipitation of cytochrome *c* oxidase (COX) and F~1~F~o~ATPase from isolated HEK293T mitochondria after digitonin solubilization. Eluates were analyzed by SDS--PAGE and Western blotting. Total, 1.5%; eluate, 100%. (B) Isolated wild-type (WT) and Atp20^ZZ^ mitochondria were solubilized and subjected to IgG chromatography. Total and eluate fractions were analyzed by SDS--PAGE, followed by immunoblot analyses with indicated antibodies. Total, 3%; eluate, 100%. (C) WT, *mio10Δ*, *atp20*Δ, and *atp2*Δ yeast cells were spotted in serial 10-fold dilutions on fermentable (glucose) and nonfermentable (glycerol) media. (D) Mitochondria (Mito) from WT, *mio10Δ*, and *fcj1*Δ were separated by SDS--PAGE and analyzed by Western blotting. (E) Solubilized mitochondria from WT and *mio10Δ* were separated by BN-PAGE and analyzed by Western blotting. Asterisk indicates nonspecific cross-reaction.](247fig2){#F2}

To address the function of Mio10 in mitochondria, we analyzed the growth behavior of a *MIO10*-deletion strain. *mio10Δ* cells displayed a growth defect on nonfermentable carbon sources, which was similar to that observed for *atp20Δ* cells but less than that with *atp2Δ* cells, which lack F~1~F~o~ATPase function ([Figure 2C](#F2){ref-type="fig"}). The growth defect of *mio10Δ* cells was not rescued by expression of MINOS1 (data not shown). We reasoned that the observed growth defect on nonfermentable carbon sources could be due to defective oxidative phosphorylation. Therefore we analyzed steady-state protein levels of *mio10Δ* mitochondria by Western blotting. However, we did not observe any significant differences compared with wild-type mitochondria with regard to the amount of the tested proteins except for Fcj1 ([Figure 2D](#F2){ref-type="fig"} and Supplemental Figure S3C). Next we addressed the organization of respiratory chain complexes by blue-native PAGE analyses (BN-PAGE). Compared to wild type, *mio10Δ* mitochondria displayed similar amounts and organization of respiratory chain *bc*~1~ complex (complexes III) and cytochrome *c* oxidase (complex IV) into supercomplexes ([Figure 2E](#F2){ref-type="fig"}, lanes 1--4). Moreover, the ratio of F~1~F~o~ATPase monomers to dimers was not affected ([Figure 2E](#F2){ref-type="fig"}, lane 5 vs. lane 6). To assess higher oligomers of the F~1~F~o~ATPase, we solubilized mitochondria in low concentration of digitonin, which maintain oligomers, and analyzed these by BN-PAGE ([@B48]; [@B67]). However, compared with wild-type mitochondria, no difference in the oligomerization of the F~1~F~o~ATPase was observed for *mio10Δ* mitochondria (Supplemental Figure S3D). Hence we concluded that the observed growth defect of *mio10Δ* cells was not due to assembly defects of the oxidative phosphorylation system.

MINOS1 is a constituent of the mitofilin complex
------------------------------------------------

Because no obvious defect in respiratory chain function or organization was detected, we analyzed mutant yeast cells for defects of mitochondrial morphology by live-cell imaging. Wild-type yeast cells expressing a mitochondria-localized green fluorescent protein (GFP) construct, pVT100U-mitoGFP ([@B69]), displayed a typical reticular mitochondrial network ([Figure 3A](#F3){ref-type="fig"} and Supplemental Movie S1). Loss of Atp20 altered mitochondrial network morphology. *atp20Δ* mitochondria appeared to have largely lost the network structure but instead appeared fragmented with thickened mitochondria ([Figure 3B](#F3){ref-type="fig"} and Supplemental Movie S2). In addition, in *mio10Δ* cells the mitochondrial network was frequently fragmented and also the mitochondria often exhibited an enlarged and flattened shape ([Figure 3C](#F3){ref-type="fig"} and Supplemental Movie S3).

![Mitochondrial morphology is altered in *mio10*Δ. Fluorescence microscopy analysis of *S. cerevisiae* wild-type, *atp20*Δ, *mio10*Δ, and *fcj1*Δ (A--D) cells transformed with plasmid pVT100U-mitoGFP ([@B69]) to visualize mitochondrial morphology. Cells were analyzed using a DeltaVision Spectris fluorescence microscope equipped with a 100× objective and a fluorescein isothiocyanate filter. For each image 10--15 Z-section images were taken at 0.5-μm intervals after focusing on the middle plane of the cell. Images were deconvoluted using softWoRx. Bars, 2.5 μm.](247fig3){#F3}

Given the severity of the mitochondrial morphology phenotype, we aimed to identify interaction partners of Mio10 in yeast mitochondria. Therefore we generated a strain expressing Mio10 with a C-terminal streptavidin tag followed by a FLAG tag (SF) from the chromosomal locus. After solubilization of wild-type or Mio10^SF^ mitochondria, Mio10-containing complexes were isolated via *Strep*-Tactin-Sepharose chromatography. Isolated proteins were separated by SDS--PAGE ([Figure 4A](#F4){ref-type="fig"}). Excised fragments covering the full Mio10^SF^ sample lane or corresponding sections of the control lane were subjected to in-gel digestion with trypsin (see *Materials and Methods*). The tryptic peptides were subsequently analyzed by high-resolution on-line liquid chromatography--tandem mass spectrometry (LC-MS/MS). Specific interacting proteins were scored based on the normalized fold change calculated using a label-free spectral count approach. Among the proteins copurifying with Mio10^SF^, we identified with highest score Fcj1, a protein required for mitochondrial inner membrane organization ([@B48]). In addition to Fcj1, uncharacterized mitochondrial proteins such as YGR235C (Mio27, Mos2, Mcs29), Aim37, and Aim13 were identified as complex constituents with high spectral counts (Supplemental Table S1). To support the mass spectrometric data, we performed Western blot analyses of the purification. As expected, Fcj1 was specifically detected in the Mio10^SF^ eluate, whereas abundant mitochondria proteins, such as subunits of the oxidative phosphorylation system (e.g., Cox2, Atp5, Cyt1) were not recovered ([Figure 4B](#F4){ref-type="fig"}). Similarly, when we purified Fcj1-ZZ-tag fusions from solubilized mitochondria, Mio10 was specifically copurified (data not shown). Next we subjected digitonin-solubilized mitochondrial fractions to gel filtration analyses. Fcj1 was detected in two protein complexes, in a low--molecular weight complex and in a large protein complex that appeared larger in size than the F~1~F~o~ATPase (\>1.2 MDa). Mio10 comigrated with Fcj1 in the gradient, further supporting their coexistence in a common complex that we refer to as the MINOS complex (mitochondrial inner membrane organizing system; [Figure 4C](#F4){ref-type="fig"}). When comparing the growth behavior of *mio10*Δ cells to *fcj1*Δ cells, we found that both mutants displayed similar growth phenotypes on nonfermentable carbon sources. In both cases, growth defects drastically increased at low temperature ([Figure 4D](#F4){ref-type="fig"}). Moreover, in vivo imaging of the mitochondrial network in *mio10*Δ and *fcj1*Δ cells revealed that they were comparable with regard to their altered mitochondrial morphology ([Figure 3D](#F3){ref-type="fig"} and Supplemental Movie S4), supporting a functional relation.

![Mio10 and MINOS1 are part of the Fcj1/Mitofilin (MINOS) complex. (A) Isolated mitochondria from WT and Mio10-Streptavidin-FLAG (Mio10^SF^) were solubilized and subjected to *Strep*-Tactin-Sepharose chromatography. Eluates were separated on SDS--PAGE and stained with colloidal Coomassie. Each gel lane was cut in 23 equal slices and proteins digested with trypsin. Peptides were analyzed by MS. (B) Total extracts and eluate fractions of *Strep*-Tactin-Sepharose chromatography using wild-type or Mio10^SF^ mitochondrial extracts were separated by SDS--PAGE and analyzed by Western blotting. Total, 3.0%; eluate, 100%. (C) Solubilized mitochondria of WT and Mio10^SF^ were subjected to separation by size exclusion chromatography and analyzed by Western blotting. (D) WT, *mio10Δ*, and *fcj1*Δ yeast cells were spotted in serial 10-fold dilutions on synthetic fermentable (glucose) and synthetic nonfermentable (glycerol) media. (E) Schematic overview of SILAC approach analyzing MINOS1-containing complexes. Mitochondria from HEK293T cells grown either in light or heavy isotope--containing medium were solubilized and subjected to coimmunoprecipitation (Co-IP) with MINOS1 antibodies or control antibodies. Eluates were mixed, separated by SDS--PAGE, and stained with colloidal Coomassie. The gel lane was cut into 23 equal slices and proteins digested with trypsin. Peptides were analyzed by LC-MS/MS. (F) Identification of MINOS10-associated proteins by Co-IP and SILAC-MS. RAW MS files from LC-MS/MS were analyzed by MaxQuant and Mascot using the IPI human protein database. Results from Maxquant were analyzed and visualized with R. Red dots indicate enriched proteins characterized by a high normalized ratio of heavy over light values (H/L). Forward, F (H, MINOS1; L, control); reverse, R (H, control; L, MINOS1; reverse ratios were inverted for plotting). (G) Isolated mitochondria from HEK293T cells were solubilized and subjected to Co-IP with MINOS1 and control antibodies Total, 1.5%; eluate 100%. Eluates were separated by SDS--PAGE and analyzed by Western blotting. (H) Solubilized mitochondria of HEK239T cells were subjected to separation by size exclusion chromatography and analyzed by Western blotting. Asterisks indicate nonspecific cross-reaction.](247fig4){#F4}

Mitofilin is the human homologue of yeast Fcj1 and maintains mitochondrial cristae organization in human and *Caenorhabditis elegans* mitochondria ([@B31]; [@B73]; [@B39]). To address whether the interaction between Mio10 and Fcj1 was conserved in human, we isolated MINOS1-containing complexes from human HEK293T cells after metabolic labeling in culture (stable isotope labeling of amino acids in cell culture \[SILAC\]; [@B45]). To eliminate false-positive hits (and to have higher stringency in discriminating specific interactors from background proteins), we performed independent SILAC immunoprecipitations, switching the labeling scheme for the control cells and the cells subjected to immunoprecipitation with anti-MINOS1 antibodies (label-swap experiment). Following immunoprecipitation with anti-MINOS1, beads were washed and bound proteins eluted, and light and heavy eluates were mixed for each experiment. Proteins were separated by SDS--PAGE and subjected to in-gel digestion ([Figure 4E](#F4){ref-type="fig"}). The resulting peptides were analyzed by high-resolution online LC-MS/MS. Mitofilin/MINOS2 was recovered in the immunoprecipitation and scored as a significant interactor. Similarly, MINOS3/CHCHD3, HSPA9, and DnaJC11, known interacting proteins of mitofilin ([@B73]; [@B13]), were recovered in the precipitate with high confidence. Because antibodies against MINOS2/mitofilin, HSPA9, and MINOS3/CHCHD3 were available, we confirmed the mass spectrometric data by Western blotting ([Figure 4G](#F4){ref-type="fig"}). All three proteins, MINOS2/mitofilin, HSPA9, and MINOS3/CHCHD3, were specifically enriched in MINOS1 immunoprecipitates, whereas other mitochondrial proteins, such as COX1 (cytochrome *c* oxidase), F1β (F~1~F~o~APTase), and TIM23 (presequence translocase), were not detected ([Figure 4F](#F4){ref-type="fig"}). Of interest, MINOS2/mitofilin has been reported to interact with the SAM complex of the outer mitochondrial membrane ([@B73]). In agreement, we found the outer mitochondrial membrane proteins Sam50 and metaxin 1 and 2 to coisolate with MINOS1, indicating that MINOS1 is part of a mitofilin-containing complex that associates with the outer membrane.

To address the size of the MINOS complex, we performed gel filtration analyses of solubilized mitochondrial extracts. MINOS1 and MINOS2/Mitofilin comigrated as a large protein complex in the gel filtration analyses and displayed an apparent molecular weight of approximately 1 MDa ([Figure 4H](#F4){ref-type="fig"}). Accordingly, MINOS1 and Mio10 are conserved components of the MINOS complex in mitochondria.

Mio10 is required for cristae morphology maintenance
----------------------------------------------------

As MINOS2/mitofilin in human and Fcj1 in yeast are essential to maintain mitochondrial cristae morphology and inner boundary membrane formation, we compared mitochondrial cristae organization of *mio10*Δ, *atp20Δ*, and *fcj1*Δ cells by electron microscopy. Using high-pressure freezing to maintain cellular structure, we analyzed mutant and wild-type yeast cells for mitochondrial morphology. Although wild-type yeast cells display the typical cristae organization of the inner mitochondrial membrane, *atp20*Δ cells showed an onion-like organization of the inner membrane ([Figure 5A](#F5){ref-type="fig"}) in agreement with previous observations ([@B47]). Similar to *atp20*Δ cells, *mio10*Δ and *fcj1*Δ cells displayed a defect in inner mitochondrial membrane morphology and loss of cristae formation ([Figure 5A](#F5){ref-type="fig"}). To address the magnitude of the defect, we performed a statistical analysis of the phenotype. We scored mitochondrial morphology into three classes (normal, intermediate, and onion-like; [Figure 5B](#F5){ref-type="fig"}, right). *atp20*Δ, *fcj1*Δ, and *mio10*Δ cells were significantly affected for loss of mitochondrial cristae morphology, and \>60% of mitochondria were scored as defective ([Figure 5B](#F5){ref-type="fig"}).

![Cristae morphology is defective in *mio10*Δ. (A) Electron microscopy of *S. cerevisiae* WT, *atp20*Δ, *mio10*Δ, and *fcj1*Δ cells after high-pressure freezing (HPF). (B) Statistical analysis of different types of mitochondria based on electron microscopy images from HPF fixed WT (n = 49), *atp20*Δ (n = 51), *mio10*Δ (n = 61), and *fcj1*Δ (n = 57) cells. Detailed view of normal, intermediate, and onion-like mitochondria types. (C) Electron microscopy of WT, *atp20*Δ, *mio10*Δ, and *fcj1*Δ cells after KMnO~4~ fixation. (D) Detailed view of WT, *atp20*Δ, *mio10*Δ, and *fcj1*Δ mitochondria shown in C. Bars, 1 μm (A, C), 200 nm (B, D).](247fig5){#F5}

To visualize the mitochondrial membranes in more detail, we used a chemical fixation protocol (see *Materials and Methods*). In these sections *atp20*Δ cells showed the typical onion-like morphology of the inner membrane ([Figure 5, C and D](#F5){ref-type="fig"}). Likewise, *mio10*Δ cells often exhibited an onion-like mitochondrial cristae organization. Furthermore, we observed a sheet-like arrangement of the inner membrane that is likely to represent a different structural organization of the inner membrane in these cells ([Figure 5, C and D](#F5){ref-type="fig"}). A similar ultrastructure with stacked membrane sheets was observed in *fcj1*Δ cells ([Figure 5, C and D](#F5){ref-type="fig"}). Previous work on *fcj1*Δ cells using tomography had indicated that these structures had lost cristae junction and were stacked by F~1~F~o~ATPase dimers ([@B48]). Thus we conclude that *mio10*Δ cells display a phenotype similar to *atp20*Δ and *fcj1*Δ cells. Therefore we refer to YCL057C-A as Mio10 for mitochondrial inner membrane organization complex constituent.

DISCUSSION
==========

The mitochondrial inner membrane is highly organized with respect to its morphology. This organization also affects the distribution of mitochondrial protein complexes and thus function ([@B65]; [@B71]; [@B60]). It has been a challenge of the field of mitochondrial biogenesis to address how inner membrane compartmentation is regulated and to identify components that are involved in maintaining inner membrane morphology. Surprisingly, an enzyme of the oxidative phosphorylation system, the oligomeric F~1~F~o~ATPase, has been found to play an important role for the organization of cristae ([@B26]; [@B47]; [@B23]; [@B64]). Mutants defective in dimerization of the F~1~F~o~ATPase due to lack of a dimerization factors such as Atp20 display severely altered mitochondrial inner membrane morphology ([@B47]; [@B5]).

Here we identified MINOS1 as a conserved protein of the mitochondrial inner membrane with a glycine-rich region reminiscent of Atp20. Previous work provided evidence that the GxxxG motif of Atp20 is involved in dimerization of Atp20 and thus promotes the process of F~1~F~o~ATPase dimerization ([@B53]). However, although we found no evidence for a physical association between the human or yeast F~1~F~o~ATPase with MINOS1 or Mio10, respectively, we identified a requirement for Mio10 in mitochondrial membrane organization. Cells lacking Mio10 displayed significantly altered mitochondrial morphology as judged by fluorescence live-cell imaging, as well as a loss of inner membrane organization. This finding is explained by the fact that human MINOS1 is a novel constituent of a large protein complex together with MINOS2/mitofilin now called the MINOS complex. In addition, other known interactors of MINOS2/mitofilin, such as MINOS3/CHCHD3, were identified in the complex. Similarly, the yeast counterpart, Mio10, is associated with Fcj1, the yeast orthologue of MINOS2/mitofilin. MINOS2/mitofilin, as well as Fcj1, was found necessary for cristae junction formation, and a loss of their function concomitantly leads to loss of typical cristae ([@B31]; [@B48]). Thus, Mio10, as a component of the MINOS complex, is apparently similarly required for inner membrane organization and morphology.

We find that MINOS1 and MINOS2/Mitofilin cooperate in inner membrane organization in a common complex. Our mass spectrometric analyses suggest a number of additional constituents of the complexes in yeast and human. However, further analyses will be required to support their presence in the MINOS complex and the functional significance of the interaction. Given the size of the MINOS complexes of \>1 MDa, it is tempting to speculate that the MINOS complexes could act as a physical scaffold for cristae junction formation ([@B31]; [@B48]). The fact that we and others found that the human MINOS2/mitofilin complex copurifies with outer membrane proteins supports a role of the complex in contact-site formation ([@B73]). High-resolution immuno--electron microscopy will be required to address this idea in the future and to provide evidence for the function of the MINOS complex in this process.

While the manuscript for this article was under revision three publications appeared that similarly report on the identification of the yeast MINOS complex ([@B27]; [@B29]; [@B66]).

MATERIALS AND METHODS
=====================

Yeast strains and growth analysis
---------------------------------

*S. cerevisiae* yeast strains used in this study were derivatives of either BY4741 or YPH499 ([@B57]). The following yeast strains were used in this study: BY4741 (Mat a, his3-Δ1 leu2Δ0 met15Δ0 ura3Δ0); YPH499 (Mat a, ade2-101 his3-Δ200 leu2-Δ1 ura3-52 trp1-Δ63 lys2-801); *mio10Δ* (Mat a, his3-Δ1 leu2Δ0 met15Δ0 ura3Δ0; *mio10*::kanMX4) (Open Biosystems, Thermo Biosystems, Huntsville, AL); *fcj1*Δ (Mat a, his3-Δ1 leu2Δ0 met15Δ0 ura3Δ0; *fcj1*::kanMX4); *atp20*Δ (Mat a, his3-Δ1 leu2Δ0 met15Δ0 ura3Δ0; *atp20*::kanMX4); *atp2*Δ (Mat a, his3-Δ1 leu2Δ0 met15Δ0 ura3Δ0; *atp2*::kanMX4); *YAA01* (Atp20^ZZ^) (Mat a, ade2-101 his3-Δ200 leu2-Δ1 ura3-52 trp1-Δ63 lys2-801; *atp20*::ATP20-ZZ-HIS3MX6), *YAA02* (Mio10-streptavidin-FLAG; SF) (Mat a, ade2-101 his3-Δ200 leu2-Δ1 ura3-52 trp1-Δ63 lys2-801; *mio10*::MIO10-SF-HIS3MX6). *YAA02* was generated using a modified pYM2.1 vector; briefly, the streptavidin-FLAG tag from a pESG-IBA_168 (cut with *Xho*I and *Bgl*II) was ligated into the pYM2.1 (cut with *Sal*I and *Bgl*II). Tagging of Mio10 (YCL057C-A) and Atp20 (YPR020W) was achieved using pYM2.1 and pYM10, respectively, as previously described ([@B32]; [@B30]).

Yeast growth tests were performed by adjusting cultured yeast to an OD~600~ of 0.1 and spotting of serial dilutions onto agar plates containing 1% yeast extract, 2% peptone, 3% glycerol (YPG) or 1% yeast extract, 2% peptone, 2% glucose (YPD). Alternatively, plates containing synthetic medium were used: 0.67% yeast nitrogen base (Difco; BD, Franklin Lakes, NJ), 0.7 g/l dropout mix of CSM-URA (MP Biomedicals, Solon, OH), or 20 μg/ml of uracil) supplemented with 2% glucose (SD) or 3% glycerol (SG) ([@B51]).

Isolation of mitochondria
-------------------------

Yeast mitochondria were isolated by differential centrifugation from cells grown on YPG at 30°C or SG at 18°C according to [@B37]).

Human mitochondria were isolated from HEK293T cells cultured in DMEM containing 10% fetal bovine serum (Life Technologies, Invitrogen, Carlsbad, CA) at 37°C and 5% CO~2~ as previously described ([@B35]; [@B51]). In brief, cells were harvested at 80--85% confluency in 1× PBS and 1 mM EDTA and homogenized in 0.1% bovine serum albumin (BSA), 300 mM trehalose, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid--KOH, pH 7.7, 10 mM KCl, and 1 mM EDTA ([@B74]). Homo­genized cells were subjected to centrifugation at 11,000 × *g* at 4°C for 10 min and the mitochondria-containing pellet concentrated in homogenization buffer without BSA.

HEK293T cells were grown in lysine- and arginine-deficient DMEM supplemented with 10% dialyzed fetal bovine serum. Light labeled medium was supplemented with normal isotope containing [l]{.smallcaps}-lysine and [l]{.smallcaps}-arginine; heavy labeled medium was supplemented with heavy isotope labeled ^13^C~6~^15^N~2~-lysine and ^13^C~6~^15^N~4~-arginine (Euriso-Top, Saarbrücken, Germany).

Protein localization analysis
-----------------------------

Protease protection and membrane association analysis was performed as previously described ([@B38]). Swelling of isolated mitochondria was achieved by treatment in EM buffer (1 mM EDTA, 10 mM 3-(*N*-morpholino)propanesulfonic acid, pH 7.2) and mitochondria lysed with 1% Triton X-100. To test protein membrane association, isolated mitochondria were suspended in 0.1 M carbonate buffer at pH 10.8 or 11.5, or alternatively lysed with 1% Triton X-100. Samples were subjected to ultracentrifugation at 45,000 rpm for 45 min at 4°C in a TLA-55 rotor (Beckman Coulter, Brea, CA). Samples were trichloroacetic acid (TCA) precipitated and subjected to SDS--PAGE analysis.

Fluorescence microscopy
-----------------------

Immunofluorescence was performed as previously described ([@B72]). Vero African green monkey (*Cercopithecus aethiops*) kidney epithelial cells grown on coverslips were fixed in 8% paraformaldehyde and permeabilized in 0.5% (vol/vol) Triton X-100. Treated cells were incubated for 1 h with C1orf151/MINOS1-antibody (rabbit) (Abcam, Cambridge, MA) and cyclophilin D antibody (mouse; Abcam) at a dilution of 1:400. After washing, cells were incubated with Oregon green 488--conjugated goat anti--mouse immunoglobulin G (IgG; 1:1000; Molecular Probes, Invitrogen) and KK114 (compound 6) conjugated goat anti--rabbit IgG (1:200; [@B33]) for 1 h. After washing, 4′,6-diamidino-2-phenylindole staining was performed for 5 min and cells embedded in mounting medium. Fluorescence microscopy was performed with a beam scanning confocal microscope (TCS SP5; Leica Microsystems, Wetzlar, Germany) equipped with 1.4 numerical aperture oil immersion lenses (63×; HCX PL APO, Leica).

Yeast cells transformed with pVT100U-mitoGFP ([@B69]) were grown overnight in selective SGG medium (0.5 g/l yeast extract, 6.7 g/l yeast nitrogen base, 0.77 g/l CSM-URA dropout mix, 30 ml/l glycerol, 1 g/l glucose). Cells were directly used for fluorescence microscopy. Images were collected by using a DeltaVision microscope (Olympus IX71; Applied Precision, Issaquah, WA) and deconvolved by using Softworx, version 3.5.1 (Great Falls, MT).

Immunoprecipitation
-------------------

Immunoprecipitation of human mitochondrial complexes was performed either with beads coupled with anti--complex IV antibodies or anti--complex V antibodies (Invitrogen). In case of MINOS1, C1orf151 antibodies were cross-linked to Protein A/G Agarose (Pierce, Thermo Fisher Scientific, Rockford, IL). One milligram of isolated mitochondria from HEK293T cells was solubilized in 1 ml of IP buffer (20 mM Tris, pH 7.4, 50 mM NaCl, 0.5 mM EDTA, 10% \[wt/vol\] glycerol, 1% \[wt/vol\] digitonin, 1 mM phenylmethylsulfonyl fluoride \[PMSF\]) for 20 min on ice. Insoluble material was removed by centrifugation (14,000 rpm, 20 min, 4°C). Total sample were taken from the supernatant. The remaining supernatant was split into aliquots and incubated with the individual antibody-coupled beads for 1 h at 4°C on an end-over-end shaker. The nonbound proteins were removed by centrifugation (1000 × *g*, 1 min, 4°C) of the samples through a minicolumn fitted with a filter. The beads were washed 10 times with W buffer (20 mM Tris, pH7.4, 50 mM NaCl, 0.5 mM EDTA, 10% \[wt/vol\] glycerol, 0.3% \[wt/vol\] digitonin, 1 mM PMSF). Samples were eluted by adding 1× SDS sample buffer.

Isolation of yeast protein complexes was performed using Atp20^ZZ^ and Mio10^SF^ strains essentially as previously described ([@B24]). Isolated mitochondria were solubilized in IP buffer. After centrifugation at 14,000 rpm for 20 min the resulting supernatants were incubated either with IgG-Sepharose or *Strep*-Tactin-Sepharose (IBA, Göttingen, Germany) for 1 h at 4°C on an end-over-end shaker. Unbound material was removed by transfer of the beads into minicolumns and centrifugation at 100 × *g* for 1 min. The beads were washed 10 times with 20× bead volume. Atp20^zz^ complexes were eluted by adding 1× SDS sample buffer. Elution of the Mio10-SF complexes was achieved by adding DB buffer (5 mM desthio-biotin, 20 mM Tris-HCl, pH 7.4, 30 mM NaCl, 0.2 mM EDTA). Mio10-SF-eluates were concentrated with StrataClean (Agilent Technologies, Santa Clara, CA).

Mass spectrometry and data analysis
-----------------------------------

Eluted proteins were separated on 4--12% gradient SDS--PAGE gels (Invitrogen) and stained with colloidal Coomassie blue. Each gel lane was cut into 23 equal gel slices, and proteins therein were in-gel digested with trypsin (Promega, Madison, WI) as described previously ([@B55]). Tryptic peptides from each gel slice were analyzed by nanoflow high-performance liquid chromatography (Agilent 1100, Agilent Technologies) coupled to a nanoelectrospray LTQ-Orbitrap XL mass spectrometer (Thermo Fischer Scientific). For yeast immunoprecipitations, the raw mass spectrometer files were searched and analyzed with Mascot (Mascot Deamon, version 2.2.2; Matrix Science, Boston, MA) and Scaffold 3 (Proteome Software, Portland, OR) using the National Center for Biotechnology Information nonredundant *S. cerevisiae* protein database. Normalized fold change ratios were calculated in Scaffold using the spectral count approach ([@B36]). For the SILAC analyses of MINOS1 immunoprecipitations, the raw MS files from the mass spectrometer were analyzed by MaxQuant ([@B12]) and Mascot using the IPI--International Protein Index human protein database, version 3.82. Results from MaxQuant were analyzed and visualized with R as described previously ([@B41]).

Size exclusion chromatography
-----------------------------

Gel filtration of human and yeast solubilized mitochondrial protein complexes were performed with an ÄKTApurifier system (GE Healthcare, Piscataway, NJ). Therefore 200 μg of isolated mitochondria was solubilized in 200 μl of GF-buffer (20 mM Tris, pH7.4, 50 mM NaCl, 0.5 mM EDTA, 10% \[wt/vol\] glycerol, 1% \[wt/vol\] digitonin, 1 mM PMSF) for 20 min on ice. Insoluble material was removed by centrifugation. The supernatants were loaded on a Superose 6 10/300 GL (GE Healthcare) equilibrated with GL buffer (20 mM Tris, pH7.4, 50 mM NaCl, 0.5 mM EDTA, 10% \[wt/vol\] glycerol, 0.1% \[wt/vol\] digitonin). The resulting fractions were precipitated with TCA and washed with acetone. Dried samples were resolved in 1× SDS sample buffer and used for SDS--PAGE.

Electron microscopy
-------------------

For high-pressure-freezing, budding yeast cells were grown at 30°C in liquid YP lactate medium (10 g/l yeast extract, 20 g/l peptone from casein, 23 ml/l L(+)-lactic acid solution \[85%\], 0.02 g/l uracil, 0.02 g/l adenine sulfate) and harvested during the logarithmic growth phase. Cells were transferred onto a 150-μm aluminum planchette and vitrified in a Leica HPM100 high-pressure freezer. The vitrified specimens were embedded using a freeze substitution unit (Leica EM AFS) in 0.5% glutaraldehyde, 0.1% uranyl acetate, and 5% H~2~O ([@B25]). After warming of the samples to room temperature the pellet was removed from the planchette, embedded in epoxide resin (Agar 100; Plano, Wetzlar, Germany), and polymerized at +80°C for 48 h. Thin sections (60 nm) were counterstained with 1% uranyl acetate in methanol and lead citrate and examined using a Philips CM 120 BioTwin transmission electron microscope (Philips, Eindhoven, Netherlands).

Chemical fixation
-----------------

Chemical fixation was performed as previously described ([@B18]). Yeast cells grown for 12 h at 18°C in liquid SGG medium were fixed in 1.5% potassium permanganate for 20 min at room temperature, poststained for 2 h with 1% uranyl acetate, and dehydrated in a graded ethanol series and embedded in Epon 812. Ultrathin sections were mounted on Formvar-coated single-hole grids and examined in a Philips EM 300.

Miscellaneous
-------------

Protein complexes were analyzed by blue native electrophoresis as previously described ([@B54]; [@B16]). In-gel ATPase activity was performed essentially as previously described ([@B6]; [@B67]). Standard techniques were used for SDS electrophoresis and Western blot analyses. Protein-antibody signals were detected by enhanced chemiluminescence (GE Healthcare). In silico analysis was performed using the *Saccharomyces* Genome Database. Multiple sequence alignment of Mio10/MINOS1 was performed with ClustalW 2.0.11 ([@B10]). TMpred ([@B28]) was used for transmembrane predictions.
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:   coimmunoprecipitation
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:   green fluorescent protein
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:   high-pressure freezing
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:   intermembrane space
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:   liquid chromatography tandem mass spectrometry
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:   mitochondrial inner membrane organization system
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:   mitochondrial inner membrane organization
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:   streptavidin-FLAG

SILAC

:   stable isotope labeling with amino acids in cell culture

TCA

:   trichloroacetic acid
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